Sensus Healthcare Analysts Downgrade Revenue and EPS Forecasts Amid Negative Sentiment
ByAinvest
Sunday, Nov 23, 2025 7:47 am ET1min read
SRTS--
Analysts have revised down their forecasts for Sensus Healthcare's (NASDAQ:SRTS) revenue and earnings per share (EPS) for 2026. The company's revenue is expected to reach $40m, a 12% improvement from the last 12 months, while losses are predicted to fall 67% to $0.06 per share. The downgrade comes after a major change in sentiment regarding the company's prospects, with a substantial drop in revenues and a shift from a profit to a loss.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet